Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Yoshimichi Sai"'
Autor:
Natsuko Ishida, Ayano Katsura, Koichi Takagaki, Hiroshi Arakawa, Tsutomu Shimada, Satoshi Mizuno, Yoshimichi Sai, Yukio Kato, Hiroyuki Nakamura, Yukio Suga, Ryo Matsushita
Publikováno v:
BMC Oral Health, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hyposalivation is treated using oral cholinergic drugs; however, systemic side effects occasionally lead to discontinuation of treatment. We aimed to investigate the effects of transdermal pilocarpine on the salivary gland skin on
Externí odkaz:
https://doaj.org/article/0729e73cfbfd442d8f37c731457705ef
Autor:
Tsutomu Shimada, Daisuke Kawakami, Arimi Fujita, Rintaro Yamamoto, Satoshi Hara, Kiyoaki Ito, Ichiro Mizushima, Shinji Kitajima, Yasunori Iwata, Norihiko Sakai, Mitsuhiro Kawano, Takashi Wada, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Background Therapeutic drug monitoring (TDM) systems generally use either liquid chromatography/tandem mass spectrometry (LC-MS/MS) or immunoassay, though both methodologies have disadvantages. In this study, we aimed to evaluate whether a C
Externí odkaz:
https://doaj.org/article/4cbdbd40e3974201aab265833e9ec354
Autor:
Yuriko Ito, Junya Nakade, Akihiro Seki, Ryosuke Gabata, Mitsuyoshi Okazaki, Shinichi Nakanuma, Arimi Fujita, Tsutomu Shimada, Taro Yamashita, Shintaro Yagi, Takumi Taniguchi, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract Background High-flow continuous hemodiafiltration (HF-CHDF) combines diffusive and convective solute removal and is employed for artificial liver adjuvant therapy. However, there is no report on dosage planning of vancomycin (VCM) in patient
Externí odkaz:
https://doaj.org/article/3b5e7d75df884c1fa092b9291a48f1dd
Autor:
Hirofumi Nagai, Tsutomu Shimada, Yoshimitsu Takahashi, Mikako Nishikawa, Hiroyuki Tozuka, Yasuto Yamamoto, Osamu Niwa, Yutaka Takahara, Arimi Fujita, Katsuhiko Nagase, Kazuo Kasahara, Seiji Yano, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract Background Gefitinib and erlotinib, are epidermal growth factor receptor tyrosine kinase inhibitors, and are currently recommended for non-small cell lung cancer stage IV in the elderly and in patients with decreased performance status in th
Externí odkaz:
https://doaj.org/article/0079c9a575984d6282c483eb99d3b786
Autor:
Yuya Futagi, Yuriko Ito, Junya Nakade, Arimi Fujita, Tsutomu Shimada, Misaki Yoshida, Yoshinori Takahashi, Mitsuhiro Kawano, Takumi Taniguchi, Yoshimichi Sai
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 722-724 (2022)
Ceftriaxone (CRO) is a long-acting third-generation cephalosporin antibiotic. We present a case of CRO-induced encephalopathy in an 84-year-old male patient with a solitary right kidney, admitted with bilateral pneumonia and right pyelonephritis. Int
Externí odkaz:
https://doaj.org/article/a48342b25b2b4e2c973cbb8e7d9c3f61
Autor:
Rikako Ueda, Naho Yamamoto, Yuki Hori, Kouji Yoshida, Koushiro Ohtsubo, Takeshi Terashima, Tsutomu Shimada, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Background Gemcitabine plus nab-paclitaxel (GnP) therapy is used for unresectable pancreatic ductal adenocarcinoma, but may cause interstitial lung disease (ILD) as a serious side effect. However, the risk factors for ILD in patients receivi
Externí odkaz:
https://doaj.org/article/34f0e58db96647bc849ca27f4f0a129a
Autor:
Shoko Shimokawa, Akiko Sakata, Yukio Suga, Kazuya Isoda, Shingo Itai, Katsuhiko Nagase, Tsutomu Shimada, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-7 (2019)
Abstract Background Ritodrine hydrochloride (RD), a β2-adrenergic agonist, is widely used as a tocolytic medication to suppress premature labor, but can cause neonatal hypoglycemia, a potentially severe side effect. We examined the incidence and ris
Externí odkaz:
https://doaj.org/article/8ff3aaf071f74f71932edd5fb3086111
Autor:
Hiroki Uda, Yukio Suga, Eriko Toriba, Angelina Yukiko Staub, Tsutomu Shimada, Yoshimichi Sai, Masami Kawahara, Ryo Matsusita
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-8 (2019)
Abstract Background Medical staff should promptly administer antimicrobials to patients with febrile neutropenia (FN) to decrease the mortality related to cancer chemotherapy. Corticosteroids, which are used in cancer chemotherapy, have a fever-suppr
Externí odkaz:
https://doaj.org/article/c372e5adfc8c47a88af946a574100225
Autor:
Hirofumi Kurokawa, Yusuke Kinari, Hiroko Okudaira, Kiyotaka Tsubouchi, Yoshimichi Sai, Mitsuru Kikuchi, Haruhiro Higashida, Fumio Ohtake
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
There have been numerous studies in which the biological role of oxytocin in trusting behavior has been investigated. However, a link between oxytocin and trust in humans was discovered only in one early study. We hypothesized that there is a large i
Externí odkaz:
https://doaj.org/article/f5ffffc8f0294613a754141ad71bb5d4
Autor:
Satsuki Hashimoto, Kyoko Honda, Kohei Fujita, Yuka Miyachi, Kazuya Isoda, Ko Misaka, Yukio Suga, Satoshi Kato, Hiroyuki Tsuchiya, Yukio Kato, Masaki Okajima, Takumi Taniguchi, Tsutomu Shimada, Yoshimichi Sai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-9 (2018)
Abstract Background Combination therapy of linezolid (LZD) and rifampicin (RFP) may be more effective than monotherapy for treating gram-positive bacterial infections, but several studies have suggested that RFP decreases LZD exposures, thereby incre
Externí odkaz:
https://doaj.org/article/a8e9927bbe194dd084a21c054444aed2